Mostrar el registro sencillo del ítem
Pretreatment levels of the serum biomarkers CEA, CYFRA 21–1, SCC and the soluble EGFR and its ligands EGF, TGF-alpha, HB-EGF in the prediction of outcome in erlotinib treated non-small-cell lung cancer patients
dc.contributor.author | Romero Ventosa, Elena Yaiza | |
dc.contributor.author | González Piñeiro, Ana Lourdes | |
dc.contributor.author | Piñeiro Corrales, María Guadalupe | |
dc.date.accessioned | 2017-06-07T07:21:23Z | |
dc.date.available | 2017-06-07T07:21:23Z | |
dc.date.issued | 2015 | |
dc.identifier.issn | 2193-180 | |
dc.identifier.uri | http://hdl.handle.net/20.500.11940/5493 | |
dc.language.iso | eng | |
dc.title | Pretreatment levels of the serum biomarkers CEA, CYFRA 21–1, SCC and the soluble EGFR and its ligands EGF, TGF-alpha, HB-EGF in the prediction of outcome in erlotinib treated non-small-cell lung cancer patients | |
dc.type | Artigo | es |
dc.authorsophos | Romero-Ventosa, E. Y. | |
dc.authorsophos | Blanco-Prieto, S. | |
dc.authorsophos | González-Piñeiro, A. L. | |
dc.authorsophos | Rodríguez-Berrocal, F. J. | |
dc.authorsophos | Piñeiro-Corrales, G. | |
dc.authorsophos | Páez de la Cadena, M. | |
dc.identifier.doi | 10.1186/s40064-015-0891-0 | |
dc.identifier.isi | 359199300002 | |
dc.identifier.pmid | 25918681 | |
dc.identifier.sophos | 19209 | |
dc.issue.number | 1 | |
dc.organization | Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Vigo - Complexo Hospitalario Universitario de Vigo::Farmacia | |
dc.organization | Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Vigo - Complexo Hospitalario Universitario de Vigo::Anatomía Patolóxica | |
dc.page.initial | 171 | |
dc.rights.accessRights | openAccess | |
dc.typesophos | Artículo Original | |
dc.volume.number | 4 |
Ficheros en el ítem
Ficheros | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |